Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)

NCT02749071 is registered in ClinicalTrials.gov with EndoStim Inc. as lead sponsor.

NCT NCT02749071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
Lead sponsor
EndoStim Inc.
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2016
Completion date
October 31, 2019
Enrollment
161 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

acid reflux, gastroesophageal reflux, gastroesophageal reflux disease (gerd), reflux, gastroesophageal